Call for Papers and Posters
Proposal for Computational and Symbolic Systems Biology Session
at the Pacific Symposium
on Biocomputing 2004
It
has become increasingly evident that the use of large-scale experimental data
and the invocation of systems biology principles are gaining widespread
acceptance in mainstream biology. The approaches to date have typically
involved a mixture of computational integration of the data and pathway
inference. The amount of research in this area has exploded in recent years, as
witnessed by the number of research presentations at meetings by the
Biopathways Consortium and the International Conference on Systems Biology.
This is the first Systems Biology session within PSB, and will include a broad
range of topics from computational systems biology, to the use of logical
inference engines in pathways and related disease mechanisms.
Large-scale
data analysis has become more common with the advent of microarray technologies
and mass spectrometry. The amount of quantitative data these yield is on the
order of thousands of individual molecular channels, and has been used to
successfully identify patterns indicative of biological responses or disease
states. However, it has become apparent that single genes or their products do
not cause most of the biological phenomena observed. The findings have drawn
researchers to the conclusion that the most interesting phenomena in biology
result from the inter-related actions of many components within the system.
Systems
Biology is a nascent field of research that continues to evolve, and in its
current form relies on a variety of novel computational approaches, including,
dynamics modeling, multivariate analysis, and Bayesian networks. Yet it is also
highly dependent on experimental design, such as how one perturbs a particular
system under investigation. Therefore, a key aspect of this field is that the
computational side is very closely tied to the experimental wet-lab side, and
focus on one without regard for the other will be inadequate. What will
differentiate this session from other computational biology programs is that it
will rely on the inclusion of experimental design models to show its full
potential.
Pathways
informatics has been a growing area of interest, as evidenced by the previous
three sessions of pathways and genomics. Research in this area is typically
divided into sub-groups that refer to metabolic, cell signaling, gene
regulatory, and protein interaction pathways. It is also clear that to some
extent these different areas are artificially defined, and that from a systems
perspective will often need to be consolidated. Therefore, research into the
interlinking of these areas will be of great interest to the general community.
Analysis of gene expression data will for the most part make sense within the
context of a system, taking into account the roles of cell signaling and
transcription factor machinery. Studies that combine different pathway
information will eventually be more successful in correctly interpreting
microarray data, than methods that simply try to “cluster” microarray patterns.
Modeling
in Systems Biology is often thought of as systems simulation, but in reality it
can involve other forms of models and therefore requires a broader definition.
Models may be numerically computable, but they also may be symbolical and
accessible to inferential logic. Logical formalisms that describe complex
phenomena are just as important as modeling molecular dynamics, and may lead to
faster insight where the computational complexities are too great for a
full-scale simulation. Work in the areas of concurrent process calculi, such as
Pi-Calculus and Ambient Calculus show some exciting new potential in life
science applications. These research topics need to be presented in parallel to
the more numerically driven approaches, since they may offer a way to merge
much of the symbolic knowledge derived already from genome research.
Although
much of Systems Biology is about thinking beyond the genome, it is obvious that
the proper utilization of genomic information when contemplating about the
“system” is critical in a comprehensive analysis. It is therefore key to
demonstrate how researchers can combine genomics information and place it in the
“context” of a systems biology framework. Since the relevance of Systems
Biology to Drug Discovery is rapidly gaining acceptance, and we are interested
in presentations from researchers members of the pharmaceutics community who
are applying Systems Biology as part of a high-throughput strategy.
This
is to be an open perspective of the field, and will include papers that
illustrate the many facets of this growing field. Topics we feel are relevant
to this session include:
Papers addressing any of
the mentioned topics (or other related topics) using multiple types of data are
welcome. The session is especially interested in combining methods for
analyzing and simulating multiple types of experimental data and will give a
strong preference towards papers that combine more than one of the following
types of data: gene expression profiles, protein expression profiles,
protein-protein interaction data, regulatory networks, disease models, and
pathway databases. Descriptions into the computational complexity and
performance of the methods are strongly encouraged, as well as demonstrating the
statistical significance of findings based on experimental data.
Individuals who cannot
submit to this session but are willing to help referee submissions are kindly
requested to contact either of the session co-chairs.
General Information on PSB
2004:
The Pacific Symposium on
Biocomputing (PSB 2004) is an international, multidisciplinary conference for
the presentation and discussion of current research in the theory and
application of computational methods in problems of biological significance.
PSB 2004 will be held January 6-10, 2004 at the Fairmont Orchid on the Big
Island of Hawaii. Tutorials will be offered prior to the start of the
conference.
PSB has been designed to be
responsive to the need for critical mass in sub-disciplines within biocomputing.
For that reason, it is the only meeting whose sessions are defined dynamically
each year in response to specific proposals. PSB sessions are targeted to
provide a forum for publication and discussion of research in biocomputing's
"hot topics." In this way, PSB provides an early forum for serious
examination of emerging methods and approaches in this rapidly changing field.
More information on the conference can be obtained from the conference web
page: http://psb.stanford.edu/.
General Information on
Papers, Abstracts, and Demonstrations:
The scientific core of the
conference consists of rigorously peer-reviewed full-length papers reporting on
original work. Accepted papers will be published in a hard-bound archival
proceedings volume (which is fully indexed in Medline), and the best of these
will be presented orally to the entire conference. Researchers wishing to
present their research without official publication are encouraged to submit a
one page abstract, and present their work in discussion, poster, and
demonstration sessions. Workstations and Internet connections will be available
for demonstrations; please submit detailed requests for demonstration
facilities along with your paper or abstract if you require them.
Paper Formatting and
Submission:
All papers must be
submitted to russ.altman@stanford.edu
in electronic format. The only acceptable file formats are Adobe Acrobat
(*.pdf) and Microsoft Word (*.doc). Attached files should be named with the
last name of the first author (e.g. altman.pdf or altman.doc). Hardcopy
submissions or unprocessed TeX or LaTeX files will be rejected without review.
Each paper must be
accompanied by a cover letter. The cover letter must state the following:
Submitted papers are
limited to twelve (12) pages in the official PSB publication format. Please
format your paper according to these instructions, which can be found at ftp://ftp-smi.stanford.edu/pub/altman/psb/.
If figures cannot be easily resized and placed precisely in the text, then it
should be clear that with appropriate modifications, the total manuscript
length would be within the page limit.
Important Dates:
Session Co-chairs: